Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
Optimal outcome for early breast cancer patients receiving adjuvant chemotherapy requires adequate dose delivery, commonly defined as >85% of planned dose of chemotherapy agents. Outside the clinical trial setting, reports from community oncology centres have demonstrated that a significant propo...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Churchill Livingstone
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/40229 |